JR, spending like it's his own $$, after these last two purchases I'm wondering if they'll be bulk sampling on current cash. Expecting more details in quarterly.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025